These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6079912)

  • 1. Relationship between tumor incompatibility and therapeutic response.
    Ferrer JF; Mihich E
    Proc Soc Exp Biol Med; 1967 Nov; 126(2):402-5. PubMed ID: 6079912
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of splenectomy on the regression of transplantable tumors.
    Ferrer JF; Mihich E
    Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor effects of kethoxal-bis(thiosemicarbazone) and 6-mercaptopurine in neonatally thymectomized mice.
    Ferrer JF; Mihich E
    Proc Soc Exp Biol Med; 1967 Mar; 124(3):939-44. PubMed ID: 6023437
    [No Abstract]   [Full Text] [Related]  

  • 4. A model system for detecting drug impairment of antitumor host defenses.
    Mihich E; Bross I; Mihich RM; Nichol CA
    Cancer Res; 1970 May; 30(5):1376-83. PubMed ID: 5426939
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of resistance against Ehrlich carcinoma by tumor cells sensitized with immunized rabbit serum.
    Kato N; Ito S; Mizuno D
    Gan; 1972 Apr; 63(2):173-9. PubMed ID: 5070236
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of ginseng polysaccharides on tumor and immunological function in tumor-bearing mice].
    Qian BC; Zang XX; Li B; Xu CY; Peng XY
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):277-80. PubMed ID: 2959029
    [No Abstract]   [Full Text] [Related]  

  • 7. Strain specificity of stimulated regression of sarcoma 180.
    Bradner WT; Pindell MH
    Cancer Res; 1965 Jul; 25(6):859-64. PubMed ID: 5834954
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on immune response of experimental tumors--observations on the immune response of lymph nodes of mice bearing implanted Ehrlich ascitic tumor or sarcoma 180 (author's transl)].
    Chen QF; Zhou SL; Liu QR
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):193-6. PubMed ID: 7227183
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of mice to Sarcoma 180 and Ehrlich carcinoma with ultraviolet-killed tumor vaccine.
    Littman ML; Kim YC; Suk D
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):7-17. PubMed ID: 5657038
    [No Abstract]   [Full Text] [Related]  

  • 10. The distribution of intraperitoneally injected colloidal particles in animals bearing implanted tumors of the mediastinum.
    Adlersberg L; Singer JM; Edberg SC
    J Reticuloendothel Soc; 1973 Dec; 14(6):571-86. PubMed ID: 4775530
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response in tumor-bearing mice.
    Kamo I; Ishida N
    Gan; 1971 Dec; 62(6):453-8. PubMed ID: 4946503
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of PHA-P reactivity of lymphocytes in tumor development by acid phosphatase activity.
    Gillissen G; Mecke P; Mecke E
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973; 80(1):45-52. PubMed ID: 4281187
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of action and cytotoxic, biochemical and histochemical effects of antibodies and complement on neoplastic cells and experimental malignant neoplasms].
    Valguarnera G
    Ann Sclavo; 1974; 16(4):367-85. PubMed ID: 4441141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acid phosphatase activity and phagocytic capabilities of reticuloendothelial system cells of mice with experimental tumors].
    Durnova GN
    Biull Eksp Biol Med; 1968 Apr; 65(4):85-7. PubMed ID: 5758481
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of therapeutically induced regression of sarcoma 180 by immunologic enhancement.
    Ferrer JF; Mihich E
    Cancer Res; 1968 Feb; 28(2):245-50. PubMed ID: 5641518
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunostimulating effect of Listeria monocytogenes, BCG and their biologically active extracts on the model of mouse ascites tumors.
    Mára M; Nedvĕdová V; Miková Z; Hyncica V
    Neoplasma; 1979; 26(6):703-10. PubMed ID: 120515
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
    Mihich E; Nichol CA
    Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
    [No Abstract]   [Full Text] [Related]  

  • 19. DIFFERENCES IN THE SELECTIVE ANTITUMOR EFFECTS OF 4-DEOXYPYRIDOXINE AND DIETARY PYRIDOXINE DEFICIENCY.
    MIHICH E; NICHOL CA
    Cancer Res; 1965 Feb; 25():153-60. PubMed ID: 14264048
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopotentiation of tumor-bearing and toxohormone treated mice by human ceruloplasmin.
    Itoh O; Torikai T; Satoh M; Okumura O; Osawa T
    Gan; 1981 Oct; 72(5):673-8. PubMed ID: 6976910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.